VA owes devicemakers $15M in late payments

Lawmakers are calling on the Department of Veterans Affairs to pay medical device companies up to $15 million in late payments for implants and devices used in VA hospitals, reports The Journal Gazette.

Advertisement

A Wednesday letter penned by Rep. Jim Banks, R-Ind., and 44 other congressman to VA Secretary David Shulkin highlights the agency’s “alarming amount of late payments” and “outstanding invoices going back as far as 2013.”

In the letter, the lawmakers claim the VA owes up to $15 million in late payments for replacement hips and knees, spine implants and cardiac pacemakers used to treat veterans through the agency’s prosthetics program. Almost one-third of these payments have been delayed for more than 90 days, according to the letter. Under federal law, the government must pay venders within 30 days of receiving an invoice receipt.

Numerous devicemakers headquartered in Mr. Banks’ Indiana districts — including Zimmer Biomet and DePuy Synthes — brought the late payments to his attention, his Banks’ Anna Swick told The Journal Gazette.

“Zimmer Biomet, along with many others in our industry, is experiencing these issues,” Monica Kendrick, Zimmer Biomet’s vice president of corporate communications, told The Journal Gazette. “We are interested in working with the VA and Congress to address them and ensure timely access to care for Veterans.”

More articles on supply chain:

Viewpoint: 4 insights into postapproval monitoring of medical devices
Interchangeable biosimilars will hit market within 2 years, says FDA leader
Hospira recall drives 2 other drug companies to pull injectables from market

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.